Am J Perinatol 2013; 30(01): 059-068
DOI: 10.1055/s-0032-1321501
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Effect of Clinical and Histological Chorioamnionitis on the Outcome of Preterm Infants

Nehad Nasef
1   Women and Babies Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
,
Abd Elazeez Shabaan
1   Women and Babies Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
,
Patti Schurr
1   Women and Babies Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
,
Dolores Iaboni
1   Women and Babies Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
,
Julie Choudhury
1   Women and Babies Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
,
Paige Church
1   Women and Babies Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
2   Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada
,
Michael S. Dunn
1   Women and Babies Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
2   Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

21 December 2011

20 March 2012

Publication Date:
06 July 2012 (online)

Preview

Abstract

Chorioamnionitis contributes to neonatal and maternal morbidity and mortality. We aimed to evaluate of the impact of clinical and histological chorioamnionitis on mortality and morbidity of preterm infants. Maternal and neonatal data were collected in a retrospective cohort of preterm infants less than 30 weeks' gestation. Infants were divided into three groups: those born to mothers with clinical chorioamnionitis, histological chorioamnionitis, or no chorioamnionitis. Of 274 identified preterm infants, 33 infants were born to mothers with clinical chorioamnionitis, 95 to mothers with histological chorioamnionitis, and 146 to mothers with no chorioamnionitis. Data were available for 180 (78%) of the 230 survivors at 18 months corrected age. Infants in the study groups were similar in gestational age, birth weight, and sex distribution. Clinical and histological chorioamnionitis were not predictive of infant mortality, cerebral palsy, bronchopulmonary dysplasia, periventricular leukomalacia, or retinopathy of prematurity. Infants in the clinical chorioamnionitis group had significantly lower cognitive (88 ± 10), language (82 ± 12), and motor (89 ± 11) scores compared with infants in the histological chorioamnionitis group (101 ± 13, p < 0.01; 91 ± 13, p < 0.05; and 99 ± 13, p < 0.05, respectively) and to infants in the no chorioamnionitis group (99 ± 13, p < 0.01; 92 ± 15, p < 0.05; and 97 ± 13, p < 0.05, respectively). Clinical chorioamnionitis is associated with developmental delay in preterm infants despite adequate treatment.